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pH-rate proﬁleGalactokinase (GALK), a member the Leloir pathway for normal galactose metabolism, catalyzes the
conversion of a-D-galactose to galactose-1-phosphate. For this investigation, we studied the kinetic
mechanism and pH proﬁles of the enzyme from Lactococcus lactis. Our results show that the mech-
anism for its reaction is sequential in both directions. Mutant proteins D183A and D183N are inac-
tive (<10000 fold), supporting the role of Asp183 as a catalytic base that deprotonates the C-1
hydroxyl group of galactose. The pH-kcat proﬁle of the forward reaction has a pKa of 6.9 ± 0.2 that
likely is due to Asp183. The pH-kcat/KGal proﬁle of the reverse reaction further substantiates this role
as it is lacking a key pKa required for a direct proton transfer mechanism. The R36A and R36N
mutant proteins show over 100-fold lower activity than that for the wild-type enzyme, thus suggest-
ing that Arg36 lowers the pKa of the C-1 hydroxyl to facilitate deprotonation.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Galactokinase, (EC 2.7.1.6), hereafter referred to as GALK, cata-
lyzes the phosphorylation of a-D-galactose, a C-4 epimer of glu-
cose, to galactose-1-phosphate utilizing MgATP as its phosphoryl
source [1–3]. It is one of four enzymes that constitute the Leloir
pathway (Fig. 1) [4–7]. Together these enzymes convert b-D-galact-
ose into glucose-1-phosphate, a compound easily converted for use
in the glycolytic pathway [4–7].
The enzymes in the Leloir pathway have been extensively stud-
ied in part because of the human diseases caused by their mutation
[8–11]. The most common defects occur in the gene encoding gal-
actose 1-phosphate uridylyltransferase leading to classical or Type
I galactosemia. Patients with Type I galactosemia suffer a wide
range of complications from speech impairment to learning dis-
abilities and neurological issues. Whereas the physiological effects
of these mutations in Type I galactosemia are complex, it is be-
lieved that galactose-1-phosphate accumulation is the major path-
ogenic factor [12]. Defects in the gene encoding GALK can lead to
Type II galactosemia, the main symptom of which is early onset
cataracts. Other than cataract formation, however, patients withType II galactosemia display a better quality of life. These individ-
uals do not accumulate high levels of galactose-1-phosphate in the
blood. As a consequence, a possible treatment for classical galacto-
semia may include the use of small molecule inhibitors of GALK to
prevent galactose-1-phosphate accumulation. In recent years, the
galactokinases have also been studied for their utility in synthesiz-
ing unnatural sugar phosphate building blocks for a process
referred to as glycorandomization [13,14].
The three-dimensional structure of GALK from Lactococcus lactis
is similar to that of human GALK as demonstrated by high-resolu-
tion X-ray crystal structures [15,16]. Both the amino acid
sequences and X-ray crystal structures place GALK in the GHMP
(galactokinase, homoserine kinase, mevalonate kinase, phospho-
mevalonate kinase) superfamily of small molecule kinases. All en-
zymes in this class are bilobal with their N-terminal motifs
dominated by a mixed b-sheet ﬂanked on one side by a-helices
and their C-terminal domains containing a four stranded anti-par-
allel b-sheet (Fig. 2a). The bacterial and human GALKs are 34%
identical and 47% similar with respect to their amino acid
sequences.
The active site of L. lactisGALK (Fig. 2b) iswedged between theN-
and C-terminal domains. Key residues involved in galactose binding
include Arg36, Glu42, Asp45, Asp183, and Tyr233. The carboxylate
side chain of Asp183 is positioned within 3.5 Å of the C-1 hydroxyl
group of galactose, whereas the guanidinium group of Arg36 is
L.A. Reinhardt et al. / FEBS Letters 587 (2013) 2876–2881 2877situated between both the C-1 hydroxyl group and an inorganic
phosphate observed binding in the active site. In order tomore fully
deﬁne the enzymatic mechanism and the roles of active site resi-
dues in L. lactis GALK, we undertook a kinetic investigation on both
the forward and reverse reactions of the enzyme and its site-direc-
ted variants (D183A, D183N, R36A, R36K) as described here.
2. Materials and methods
2.1. Materials
Tris(hydroxymethyl)aminomethane buffer was from Fisher Sci-
entiﬁc (Pittsburgh, PA). All other chemicals were from Sigma (St.
Louis, MO). All chemicals were reagent grade and used without fur-
ther puriﬁcation. Initial rate measurements were measured on a
Cary 300 UV–VIS spectrometer equipped with a Varian tempera-
ture controller.
2.2. Site-directed mutagenesis and protein overexpression and
puriﬁcation
Site-directed mutant proteins were generated using the Quik-
Change method of Stratagene. Protein overexpression and puriﬁca-
tion was performed following the procedures as described in Ref.
[15]. Protein concentrations were calculated using the extinction
coefﬁcient of 1.75 ml/(mg cm) as determined by the program Pro-
tean (DNAstar, Inc., Madison, WI).
2.3. Enzyme assays for forward and reverse reactions of GALK (L.
lactis)
Initial velocities were measured by monitoring changes in
NADH (NADP) concentration for coupled assay reactions at
340 nm (e = 6.22 L/mM1 cm1) at 24 C. The rates for the forward
reaction with galactose as substrate were measured using the
pyruvate kinase (PK)/lactate dehydrogenase (LDH) coupled assay.
The rates for the reverse reaction with galactose-1-phosphate as
substrate were monitored using the hexokinase (HK)/glucose-6-
phosphate dehydrogenase (G-6-P-DH) coupled assay. Background
rates were subtracted, and coupling enzyme concentrations were
chosen so their reactions were not rate limiting.Fig. 1. The Leloir Pathway. Four enzymes are required for galactose metabolism in most o
galactose by the action of a mutarotase. This is required because GALK, the next enzyme
anomer. The product of the GALK reaction, galactose-1-phosphate, is subsequently conv
The products of the uridylyltransferase reaction are glucose-1-phosphate and UDP-galac
4-epimerase.2.4. Speciﬁc activities of wild-type GALK and the R36K, R36A, D183N,
and D183A mutant proteins at pH 8
The forward reaction (1 ml) assay contained HEPES (150 mM,
pH 8), magnesium acetate (3 mM), DTT (0.1 mM), PEP (0.4 mM),
NADH (0.4 mM), PK (50 U/ml), LDH (85 U/ml), MgATP (1.5 mM),
and enzyme (0.087–225 lg). The reverse reaction assay contained
HEPES (75 mM, pH 8), magnesium acetate (3 mM), galactose-1-
phosphate (2 mM), glucose (3 mM), NADP (1 mM), ADP (3 mM),
HK (60 U), (G-6-P-DH) (92 U), and enzyme (2.8–225 lg). Assay
components were allowed to incubate 5 min before initiation.
The enzyme stock solutions were diluted with bovine serum albu-
min (0.15%), DTT (0.1 mM), and HEPES (100 mM, pH 8).
2.5. Determination of kinetic parameters for the wild-type GALK
forward reaction at pH 8
The same conditions as forward speciﬁc activity experiments
except varied concentrations of MgATP (0.03–0.9 mM) and galact-
ose (0.3–2 mM) were used for a 3 ml assay volume, and the
reaction was initiated with galactokinase. ATP and galactose con-
centrations were determined by UV analysis and endpoint assay,
respectively.
2.6. Determination of pH-rate proﬁles for GALK in the forward and
reverse reactions
The buffers used included the following: MES (pH 6–6.5), HEPES
(pH 7–8), TAPS (pH 8.5–9) with a 1–3 ml volume. Enzyme pH sta-
bility was evaluated by preincubation at different pH values. The
rates of the forward kinetic reactions were measured at galactose
concentrations (0.5–2 mM) while those of the reverse reaction
were run with varying galactose-1-phosphate (0.1–18 mM). The
MgATP (1.5 mM) or MgADP (3 mM) concentrations were ﬁxed.
2.7. Data analysis
The kinetics data for sequential mechanisms were ﬁtted to Eq.
(1) [17]. The kinetic data used to obtain the kinetic parameters
for the pH proﬁles were ﬁtted to the Michaelis–Menten equation
Eq. (2) [18,19], and the data for pH proﬁles were ﬁtted to Eqs.rganisms. The Leloir pathway initiates with the conversion of (b-D-galactose to a-D-
in the pathway and the focus of this investigation, is absolutely speciﬁc for the a-
erted to its UDP analog by the action of galactose-1-phosphate uridylyltransferase.
tose. In the last step, UDP-galactose is epimerized to UDP-glucose by UDP-galactose
Fig. 2. The structure of the L. lactis GALK. A ribbon representation of the GALK monomer is displayed in (a). A closeup stereo view of the active site is presented in (b). Protein
residues shown are located within 3.2 A of the bound ligands.
Table 1
Speciﬁc activities (U/mga) of GALK (L. lactis) and mutant proteins.
2878 L.A. Reinhardt et al. / FEBS Letters 587 (2013) 2876–2881(3)–(5) (6) depending on whether the proﬁle was a symmetrical
(Eq. (3)) or a half-bell shape with an acidic (Eq. (4)) or basic break
(Eq. (5)) [17]. A and B are substrate concentrations. Ka and Kb are
Michaelis constants for substrates A and B, while Kia is the dissoci-
ation constant for A from the EA complex.
m ¼ VAB
K iaKb þ KaBþ KbAþ AB ð1Þ
m ¼ VA=ðK þ AÞ ð2Þ
Log y ¼ Log½C=ð1þ Kl=HþH=K2Þ ð3Þ
Log y ¼ Log½C=ðlþH=KÞ ð4Þ
Log y ¼ Log½C=ð1þ K1=Hþ K1K2=H2Þ ð5ÞEnzymeb Speciﬁc activity forward Rxn
(U/mg)
Speciﬁc activity reverse Rxn
(U/mg)
GALK 11.5 ± 0.3 0.43 ± 0.02
D183N No activityc No activityc
D183A No activityc No activityc
R36K 0.100 ± 0.009 0.0043 ± 0.0002
R36A 0.080 ± 0.008 0.0067 ± 0.0002
a A unit is deﬁned as that amount of enzyme that phosphorylates 1 lmole of D-
galactose per min at 24 C in HEPES (150 mM, pH 8).
b His-tagged.
c <10000 fold activity of GALK.3. Results
3.1. Speciﬁc activities of wild-type GALK and the R36K, R36A, D183N,
and D183A mutant proteins at pH 8
Site-directed variants of Arg36 and Asp183 were prepared to
examine their roles in catalysis. Table 1 lists the speciﬁc activities
measured. The speciﬁc activity of recombinant His-tagged GALK is
11.5 U/mg. Both Asp183 mutants of GALK, D183A and D183N,show no activity (<10000 fold). The Arg36 mutants have over
100-fold less activity for the forward reaction. The low or absent
activities of the arginine and aspartate GALK mutants, respectively,
are consistent with results from other GALKs (rat and human) [20–
24] and point to the likelihood of key roles for these conserved
residues in catalysis. In addition, in the reverse reaction both
R36A and R36K display approximately two orders of magnitude
less activity (64- and 100-fold).
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Fig. 3. Steady-state kinetic analysis for R36K GALK mutant protein in the forward
enzymatic reaction at pH 8 and 24 C. MgATP concentrations: 0.03 mM (j),
0.045 mM (N), 0.08 mM (}Þ, and 0.9 mM (.).
L.A. Reinhardt et al. / FEBS Letters 587 (2013) 2876–2881 28793.2. Determination of kinetic parameters for GALK and variants in the
forward reaction
The steady-state kinetic parameters at pH 8.0 were determined
in the forward direction by varying both galactose and MgATP at
24 C. The initial velocity plot for R36K is shown in Fig. 3, and all
the kinetic parameters are given in Table 2. All GALK variantsTable 2
Steady-state kinetic parameters for the GALK variants (L. lactis) at 24 C.
Enzymea kcatðs1Þb KGal (mM) KMg
GALK 11.0 ± 0.5 0.48 ± 0.05 0.0
R36K 0.45 ± 0.04 1.0 ± 0.2 0.0
R36A 0.15 ± 0.02 1.8 ± 0.3 0.
a His-tagged.
b 46 kDa used for molecular weight of monomer.
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Fig. 4. Plot of pH-rate for wild-type GALK. (a) pH-kcat/KGal proﬁle of the forward reaction
pH-kcat/KGal-1-P proﬁle of the reverse reaction ﬁtted with Eq. (5). (d) pH-kcat proﬁle of thstudied here have intersecting initial velocity patterns. The kinetic
parameters for GALK (Kcat 5.5, KGal 0.34 mM, KMgATP 0.03 mM) and
recombinant His-tagged GALK are similar indicating that theHis-
tag does not signiﬁcantly change the protein conformation. The ki-
netic parameters for L. lactis GALK are similar in magnitude to
those found for galactokinases from Escherichia coli (KGal
0.64 mM, KMgATP 0.066 mM) and human (KGal 0.97 mM, KMgATP
0.034 mM, and kcat 8.7 s1) [20–23]. From their amino acid se-
quences, the bacterial and human GALK are 34% identical and
47% similar. The activities (Kcat) of Arg36 mutant proteins are 2 or-
ders of magnitude lower than the wild-type enzyme. The values
ofKGal and KMgATP are 2- to 4-fold larger for the arginine mutant
proteins, except for KMgATP for R36K that is 3-fold smaller. The
mutational effects on the kinetic parameters values for the analo-
gous arginine to alanine mutants of rat GALK and especially the
arginine to lysine human GALK are more modest [21,22].
3.3. pH-rate proﬁles for wild-type GALK for the forward and reverse
reactions
pH-rate analysis was performed using galactose as the varied
substrate over the pH range 6–9 (Figs. 4, 5). For the forward reac-
tion the pH-kcat/KGal proﬁle is a symmetrical bell shaped curve
(Fig. 4a) with slopes on either side of the maximum of 1 or 1.
The two residues with ionizing groups in this pH range have pKa
values of 7.1 ± 0.2 and 8.9 ± 0.3. The maximal rate is observed
when one group is deprotonated and one group isprotonated.ATP (mM) kcat/KGal(L/mol s) kcat/KMgATP(L/mol s)
53 ± 0.007 23000 ± 1000 207000 ± 9000
18 ± 0.008 450 ± 40 25000 ± 2000
14 ± 0.04 81 ± 9 1000 ± 100
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ﬁtted with Eq. (3). (b) pH-kcat proﬁle of the forward reaction ﬁtted with Eq. (4). (c)
e reverse reaction.
2880 L.A. Reinhardt et al. / FEBS Letters 587 (2013) 2876–2881The forward pH versus kcat plot (Fig. 4b) has a break in the acidic
side with a slope of 1. The pKa of the ionizing group is 6.9 ± 0.2.
For the reverse reaction, the pH-kcat/KGal-1-P proﬁle (Fig. 4c) has a
break in the basic side at pKa7.5 ± 0.1. The slope is 2 indicating
two groups must be protonated for optimum activity. The pH-kcat
proﬁle (Fig. 4d) is somewhat bell shaped. For the reverse reactions
of R36K GALK thepH-kcat/KGal-1-P proﬁle plateaus from pH 6.3 to pH
8 before decreasing (Fig. 5a), while the pH-kcat proﬁle (Fig. 5b) is
bell-shaped with pKa values of 6.7 ± 0.2 and 7.8 ± 0.2 with slopes
of 1 or 1.
4. Discussion
In addition to an overall bilobal appearance, members of the
GHMP kinase superfamily contain three conserved Motifs I–III that
enable them to phosphorylate small molecule substrates. Motif I is
composed of residues that are involved in binding the sugar or sub-
strate to be phosphorylated, whereas Motif II residues envelop the
phosphoric moiety of MgATP. Motif II residues reside near the c-
phosphate group of the nucleotide. Strikingly, the catalytic
mechanisms (Fig. 6) of the enzymes in the GHMP superfamily vary
considerably. For instance, in E. coli homoserine kinase, which
catalyzes the phosphorylation of homoserine to O-phospho-L-
homoserine, the mechanism (Fig. 6a) is believed to proceed by
direct transfer of a proton from the substrate hydroxyl group to
the c-phosphoryl group of MgATP as the hydroxyl oxygen attacks
the c-phosphorus of the nucleotide [24,25]. Precedent for this
direct transfer exists [26–28]. On the other hand, with mevalonate
kinase, the ﬁrst step (Fig. 6b) is instead deprotonation of theFig. 5. Plot of pH-rate for R36K GALK. (a) pH-kcat/KGal-1-P of the reverse reaction. (b)
pH-kcat proﬁle of the reverse reaction ﬁtted with Eq. (3).
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Fig. 6. Proposed catalytic mechanisms for members of the GHMP superfamily. (a)
Direct proton transfer (b) proton transfer by catalytic base.substrate C-5 hydroxyl by a conserved active site aspartate
[29,30] followed by nucleophilic attack on the c-phosphate to form
mevalonate-5-phosphate. An active site lysine is proposed to lower
the pKa of this hydroxyl to facilitate its deprotonation. Galactokin-
ases andmevalonate diphosphate decarboxylase also likely fall into
this group [15,16,20–23,31].
The active site of GALK [15] is located between the N- and C-ter-
minal domains as shown in the X-ray structure of L. lactis GALK
complexed with galactose and inorganic phosphate. Key residues
(Fig. 2b) involved in anchoring galactose to the protein include
the guanidinium group of Arg36, the carboxylate groups of Glu42,
Asp45, and Asp183, and Og of Tyr233. Also, Gly347 and Ala348 re-
side in close proximity on one side of the sugar. The carboxylate
side chain of Asp183 is positioned within 3.5 Å of the C-1 hydroxyl
group of galactose, whereas the guanidinium group of Arg36 is sit-
uated between both the C-1 hydroxyl group and the inorganic
phosphate. Both residues are conserved in all galactokinases known
to date. Shown in Table 1, both the D183A and D186N mutant pro-
teins have no activity (<10000 fold), likely implicating Asp183 as
the catalytic base that accepts a proton from the C-1 hydroxyl group
of galactose, as in other GALKs [20–23]. Both the R36A and R36K
GALKs have much reduced but measurable activity (Table 1) indi-
cating that the arginine also has an important role in catalysis.
GALK phosphorylates galactose to galactose-1-phosphate in a
reversible reaction. The kinetic mechanisms for the R36K and
R36K mutant proteins and the wild-type enzyme are sequential
as shown by the intersecting lines in the initial velocity plot that
converge to the left of the ordinate. Thus both substrates add to
the enzyme before products dissociate. The same mechanism has
been found for galactokinases from other sources (E. coli, human)
[20–23]. Presumably this bacterial enzyme’s mechanism is random
similar to that of GALK from E. coli [23]. Small molecules kinases
with sequential mechanisms have been shown to function with
random addition of substrates, although the tighter binding of
the nucleotide over the other substrate can allow it to appear
otherwise.
The R36K and R36A mutant proteins have kcat and kcat/Km val-
ues reduced 2–3 orders of magnitude (Table 2) compared to the
wild-type enzyme. The magnitude of the reductions suggests an
important role for this residue. The positively charged arginine res-
idue may lower the pKa value of the C-1 hydroxyl (3.0 Å apart) so
that it may be deprotonated more readily, and it may also inﬂuence
the environment around Asp183. The positive charge may also sta-
bilize a negatively charged transition state formed in the nucleo-
philic attack on the c-phosphate of MgATP.
The Km values of the arginine mutants are not affected to the
same degree as those of kcat and kcat/Km. The values of KGal and
KMgATP are 2- to 4-fold larger for the arginine mutant proteins, ex-
cept notably for KMgATP for R36K that is 3-fold smaller. As shown in
Fig. 2b, Arg36 may act as a bridge between the substrates, galact-
ose and MgATP. The positive charge on this residue may help sta-
bilize the negatively charged phosphate group. Lysine is also a
positively charged residue, but it has a more mobile or ﬂexible
reach. This ﬂexibility may enable it to bind more tightly to MgATP,
lowering KMgATP while concomitantly increasing KGal, although this
interpretation depends on the substrates ability to freely dissociate
from the enzyme.
The pH dependence of the kinetic parameters was measured for
L. lactis GALK for both the forward and reverse reactions. In active
sites of enzymes, certain ionizable groups of substrates or enzy-
matic residues may be required to reside in the correct form to al-
low for proper substrate binding, enzymatic conformation or
catalytic reaction. These pH-rate proﬁles may allow the measure-
ment of the pKa values of these groups along with the optimum
pH at which the enzymatic reaction occurs. The pH proﬁle for kcat/
KGal of the forward reaction showed pKa values of ionizing groups
L.A. Reinhardt et al. / FEBS Letters 587 (2013) 2876–2881 2881at 7.1 ± 0.2 and 8.9 ± 0.3 with a pH optimum for the reaction at 8.0
(Fig. 4a). While both groups responsible for these pKa values are
important for substrate binding, only a group at 6.9 ± 0.2 is impor-
tant in the catalytic reaction as determined from the pH-kcat proﬁle
(Fig. 4b). The sugar substrate galactose (pKa 12.4) must be deproto-
nated in either mechanism (Fig. 6), but if its pKa is 6.9 in the active
site then the positively Arg36 would have lowered its pKa over 5
units. Alternatively, Asp183 must be deprotonated to function as
the catalytic base and may have a pKa value in this range in a suit-
able environment. Overall in this enzyme’s active site the positive
charge of Arg36 is balanced by the negative charge of Asp183 and
MgATP. Asp183 is very likely responsible for the pKa at 6.9.
Importantly, for the reverse reaction of GALK, the kca/KGal-1-P has
a break in the basic side at pKa 7.5 ± 0.1 (Fig. 4c). For the reverse
reaction of that shown in Fig. 6a to occur without a catalytic base,
the monoanion form of galactose-1-phosphate 1 would be the re-
quired substrate. This phosphorylated-sugar substrate has a pKa
of 6.2. If GALK followed the samemechanism as homoserine kinase
that does not have aspartate or arginine residues or suitable substi-
tutes placed correctly in its active site to participate in the reaction,
it would have a break in pH-kcat/KGal-1-P proﬁle at 6.2. As this is not
observed, the role of Asp183 as the catalytic base for this enzyme is
substantiated. Asp183 is protonated for the reverse of the reaction
shown in Fig. 6b.
1
O
HO OH
HO
O
Ph
P
OH
O-
Omonoanion
Although the reverse reaction wild-type pH-kcat proﬁle (Fig. 4d)
is not well deﬁned, that for R36K GALK is symmetrical with pKa
values of 6.7 ± 0.2 and 7.8 ± 0.2 (Fig. 5b). The R36K mutant protein
pH-kcat/KGal-1-P proﬁle shows a plateau as the pH changes from 6.3
to 8 before decreasing (Fig. 5a). The pKa value of Asp183 has de-
creased 0.2 pKa unit to 6.7 with the modiﬁcation from Arg36 to
Lys36. Minor changes in the active site are expected with this sub-
stitution even though both residues are positively charged.
These kinetic and pH-rate studies provide substantial evidence
of a general base mechanism for GALK. Both the catalytic base role
of Asp183 and pKa of the residue have been deﬁned. The role of
Arg36 in positioning the substrates, galactose and MgATP, has also
been shown by modiﬁcations in KGal and KMgATP values.
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